•
Jun 30, 2023
Ekso Bionics Q2 2023 Earnings Report
Reported record revenues driven by increased EksoHealth device bookings.
Key Takeaways
Ekso Bionics reported record revenues of $4.7 million in Q2 2023, a 36% increase year-over-year, driven by a record number of EksoHealth device bookings. Gross profit also increased to $2.3 million, with a gross margin of approximately 48%.
Achieved record revenues of $4.7 million in Q2 2023, a 36% increase year-over-year.
Booked a total of 44 EksoHealth devices in Q2 2023.
Gross profit of $2.3 million in Q2 2023, compared to $1.6 million in the same period last year.
Cash position of $13.3 million at June 30, 2023.